Table 3.
The detection of specific serum IgM antibodies to five viruses in the intention-to-treat analysis.
| Viruses | Experimental group |
Control group |
χ2 | p | ||
|---|---|---|---|---|---|---|
| Total, N | Positive of serum IgM, N (%) | Total, N | Positive of serum IgM, N (%) | |||
| ADV | 234 | 7 (3.0) | 240 | 17 (7.1) | 4.127 | 0.042 |
| RSV | 256 | 2 (0.8) | 255 | 7 (2.8) | 1.826 | 0.177 |
| Flu-A | 472 | 30 (6.4) | 460 | 104 (22.6) | 49.988 | 0.000 |
| Flu-B | 519 | 22 (4.2) | 520 | 84 (16.2) | 40.251 | 0.000 |
| PIV1-3 | 544 | 22 (4.0) | 545 | 86 (15.8) | 41.971 | 0.000 |